newsfilter
← Latest News
Business Wire·

Epizyme to Participate in Jefferies London Healthcare Conference

Epizyme, Inc. (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that Grant Bogle, President and Chief Executive Officer of Epizyme, will present at the J